Argenx Wins FDA Approval Expanding Vyvgart Use to All Serotypes of Generalized Myasthenia Gravis
Idag, 09:51
03:51 AM EDT, 05/11/2026 (MT Newswires) -- Argenx (ARGX) has secured the approval of the US Food and Drug Administration for a label expansion for Vyvgart and Vyvgart Hytrulo, extending the use to all serotypes of adult patients living with generalized myasthenia gravis, the company said late Friday.
The approval was supported by data from a phase 3 trial, which showed "rapid, significant and sustained improvements"in symptoms across serotypes, Argenx said.
Ämnen i artikeln
Argenx Wins FDA Approval Expanding Vyvgart Use to All Serotypes of Generalized Myasthenia Gravis
Idag, 09:51
03:51 AM EDT, 05/11/2026 (MT Newswires) -- Argenx (ARGX) has secured the approval of the US Food and Drug Administration for a label expansion for Vyvgart and Vyvgart Hytrulo, extending the use to all serotypes of adult patients living with generalized myasthenia gravis, the company said late Friday.
The approval was supported by data from a phase 3 trial, which showed "rapid, significant and sustained improvements"in symptoms across serotypes, Argenx said.
Ämnen i artikeln
Analys
Lyxsektorn
Analys
Lyxsektorn
Marknadsöversikt
1 DAG %
Senast
1 mån
